Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial) - Chen, Li; Zhu, Hong-Ming; Li, Yan; Liu, Qi-Fa; Hu, Yu; Zhou, Jian-Feng; Jin, Jie; Hu, Jian-Da; Liu, Ting; Wu, De-Pei; Chen, Jie-Ping; Lai, Yong-Rong; et al. (Proceedings of the National Academy of Sciences - PNAS, 2021)
Keywords: Acute promyeloid leukemia; Anthracycline; Arsenic; Arsenic trioxide; Biological Sciences; Chemotherapy; Consolidation; Cytarabine; Evaluation; Induction therapy; Leukemia; Promyeloid leukemia; Remission; Retinoic acid; Risk groups; Toxicity; all-trans retinoic acid; acute promyelocytic leukemia; risk stratification; arsenic trioxide; consolidation therapy